On its website, TODAY (4/19, Pawlowski, 1.85M) reports the Food and Drug Administration has identified 359 women with “breast implant-associated anaplastic large cell lymphoma (ALCL), a type of non-Hodgkin’s lymphoma,” since a link was discovered between breast implants and the rare form of cancer in 2011. The article reports that nine of the women identified … Continue reading Amarillo’s Top Product Liability Attorney Offers Free Consultations: FDA has identified 359 women with rare cancer linked to breast implants
Tagged AAJ, ALCL, Amarillo Wrongful Death, anaplastic large cell lymphoma, breast implant, Cancer, FDA, non-hodgkin's lymphoma, product liability, textured implant, US Food and Drug Administration, Wrongful Death,
The New York Times (4/29, B2, Pollack, Subscription Publication) reports that drugmaker Takeda Pharmaceutical announced Tuesday that it has agreed to a $2.4 billion settlement to “resolve most of the product-liability lawsuits related to” Actos (pioglitazone), the company’s diabetes drug that allegedly “caused bladder cancer.” In accepting the settlement, Takeda “did not admit liability” and … Continue reading Dangerous Drugs: Takeda agrees to $2.4B settlement in case over diabetes drug allegedly linked to bladder cancer.
CBS News (4/21, Firger) reports on its website that a meta-analysis “of two decades worth of research – 12 trials that involved more than 300,000 people –” showed that “a number of supplements actually made a person much more likely to develop certain types of cancer” rather than protect against the disease. The analysis revealed … Continue reading Dangerous Drugs: Research Suggests Dietary Supplements May Increase Risk of Cancer.